Opaleye Management Inc. Syros Pharmaceuticals, Inc. Transaction History

Opaleye Management Inc.

  • $390 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$10.16 - $13.65 $752,591 - $1.01 Million
-74,074 Closed
0 $0
Q4 2017

Feb 09, 2018
SELL
$8.45 - $17.48 $359,124 - $742,900
-42,500 Reduced 36.46%
74,074 $720,000
Q3 2017

Nov 14, 2017
BUY
$13.52 - $23.75 $1.58 Million - $2.77 Million
116,574
116,574 $1.72 Million

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email